D.L. Carlson Investment Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,073
Closed -$941K 141
2024
Q1
$941K Sell
7,073
-752
-10% -$97.6K 0.18% 96
2023
Q4
$984K Sell
7,825
-1,279
-14% -$168K 0.2% 93
2023
Q3
$1.11M Sell
9,104
-325
-3% -$43.3K 0.22% 87
2023
Q2
$1.33M Sell
9,429
-439
-4% -$60.5K 0.25% 83
2023
Q1
$1.4M Sell
9,868
-901
-8% -$129K 0.32% 76
2022
Q4
$1.69M Sell
10,769
-110
-1% -$15.8K 0.36% 71
2022
Q3
$1.33M Sell
10,879
-260
-2% -$34.2K 0.29% 74
2022
Q2
$1.48M Sell
11,139
-1,473
-12% -$201K 0.31% 74
2022
Q1
$1.73M Sell
12,612
-1,750
-12% -$244K 0.29% 75
2021
Q4
$2.48M Sell
14,362
-12
-0.1% -$1.83K 0.4% 67
2021
Q3
$2.09M Buy
14,374
+250
+2% +$36.6K 0.36% 71
2021
Q2
$1.86M Sell
14,124
-235
-2% -$30.8K 0.32% 79
2021
Q1
$1.84M Sell
14,359
-200
-1% -$24.6K 0.34% 76
2020
Q4
$1.74M Sell
14,559
-50
-0.3% -$6.09K 0.31% 79
2020
Q3
$1.67M Sell
14,609
-28,181
-66% -$3.33M 0.35% 73
2020
Q2
$4.88M Sell
42,790
-6,671
-13% -$708K 1.45% 22
2020
Q1
$3.97M Buy
49,461
+23,988
+94% +$2.48M 1.5% 16
2019
Q4
$2.72M Buy
25,473
+1,099
+5% +$115K 0.79% 43
2019
Q3
$2.61M Buy
+24,374
New +$2.5M 0.82% 46

Other funds holding DGX

D.L. Carlson Investment Group's DGX Position: Q2 2024 in Review

D.L. Carlson Investment Group sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 7,073 shares — an estimated $941K sold.

D.L. Carlson Investment Group first reported a position in DGX in Q3 2019 and held it in 19 quarters. The position peaked at $4.88M in Q2 2020. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • D.L. Carlson Investment Group reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 7,073 Quest Diagnostics shares in Q2 2024, an estimated $941K.
  • D.L. Carlson Investment Group first reported a position in Quest Diagnostics in Q3 2019 and held it in 19 quarters.
  • D.L. Carlson Investment Group's Quest Diagnostics position peaked at $4.88M in Q2 2020.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.